Web notes  

June 2018
FUNDING OPPORTUNITIES- Back

WW Smith Charitable Trust Heart Disease, Cancer and AIDS Research Grants

Internal deadline: June 8, 2018

The W. W. Smith Charitable Trust is a private foundation specifically focused on areas involving basic needs for food, clothing and shelter; supplementing higher education scholarship programs; supporting maritime education/maritime heritage preservation; and basic medical research primarily in Heart Disease, Cancer and AIDS. The W.W Smith Charitable Trust will make grant funds available for eligible scientists in support of basic heart disease, cancer and AIDS research projects. The Trust highlights the importance of basic medical research in the area of Juvenile Diabetes and continues to provide funds for finding a cure. The philosophy of the Trust has been not to replicate governmental funding organizations, but identify and fund projects that are unique and meritorious. The estimated award amount is $100,000 for each of the 3 areas.

For more information, visit the WW Smith Charitable Trust website and click "download medical application." Enter "wwsctmed216" when prompted for the application password in order to view the detailed information.

Eligibility & Requirements:

  • Faculty with primary appointments in universities, hospitals and research centers within the Delaware Valley area may apply.
  • The Trust will not support large general programs or project grants fund research centers.

Internal Nomination Process:
Interested applicants should submit the following documents:

  1. JHU Limited Submission Cover Sheet
  2. Statement identifying area of research (heart disease, cancer or AIDS) for which you are applying
  3. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit)
  4. Curriculum Vitae of investigator, including current external research support and publications
  5. Budget (two pages maximum)

Questions? Comments? Email the Research Development Team at resapp@jhu.edu.


Mallinckrodt Foundation Grants for Early-Career Faculty

Internal Deadline: June 14, 2018

The Edward Mallinckrodt, Jr. Foundation is a private foundation that funds basic biomedical research to support early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. Investigators should bear in mind that the Board selection process is shepherded by Trustees with a medical, scientific background, but the lay summary is critical to connecting to the lay members of the Board who ultimately have an important role in the final selection of award recipients. Institutions and their research offices should bear in mind that given the number of applications we receive, that we are very interested in the selection process that results in an investigator's sponsorship for an EMF grant. We examine closely the support the institution will provide and the promise the institution sees for their proposed investigators' submissions. Proposals must contain an adequately detailed description of the project to be clearly understandable by the scientific members of the Trustees. They need not be in the detail requested by the NIH for R01 grants and should not exceed five pages in length. Additional material can be submitted, but the five page application should contain the essential information. References should also be included to support the proposal. Note that the five page limit is only for the project description.

Eligibility Requirements:

  • Applicants must hold M.D. and/or Ph.D degrees and should be in the first to fourth year of their tenure track faculty position.
  • Investigator cannot have current R01 funding.

Internal Nomination Process:
Interested applicants should submit the following documents:

  1. JHU Limited Submission Cover Sheet
  2. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit)
  3. Applicant's NIH biosketch (5 pages)
  4. Budget (two pages maximum)

Questions? Comments? Email the Research Development Team at resapp@jhu.edu.


Funding for Prostate Cancer Research

DEADLINE: Monday, July 16, 2018 by 5:00PM (EST)

Funding is available to support multidisciplinary research in prostate cancer through the Patrick C. Walsh Prostate Cancer Research Fund, the SPORE Development Research Program (DRP), and the SPORE Career Enhancement Program (CEP). Awards are for one year and a maximum of $100,000, with an exception for the SPORE CEP. The CEP awards will be given as 2-year awards at $50,000 per year. Investigators will be allowed to request a 1-year no cost extension at the end of the award period with proper scientific justification.

Funding is open to all JHU affiliated faculty. Partnership with a Brady Urological Institute faculty member is highly encouraged, but not required. An emphasis will be placed on funding research with a high priority given to project innovation as well as collaboration with basic science, data science, and engineering faculty.

Funds are to be used for supporting the proposed research application, however they should not be used to support PI salary. Awardees will be notified in mid to late August (2018). The award period will be from September 1, 2018 through August 31, 2019. For more information, visit the website at http://urology.jhu.edu/PCW/index.php.

Applications should be submitted using the application portal at https://public.onc.jhmi.edu/pilotProjects/ by Monday, July 16, 2018. Please be certain that you are submitting an application for the Patrick C. Walsh Prostate Cancer Research Fund.

Questions regarding the application process should be directed to David "Brandy" Yeater via email (dyeater1@jhmi.edu).


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.


Return to top of Funding Opportunities

 
   
June 2018 articles:
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Change in Federalwide Assurance [FWA] Numbers
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
NIH requirement for Single IRB (sIRB)
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
WW Smith Charitable Trust Heart Disease, Cancer and AIDS Research Grants
Mallinckrodt Foundation Grants for Early-Career Faculty
Funding for Prostate Cancer Research
Michael J. Fox Foundation (MJFF) Challenge
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization

This Month's Departmental Listings

Upcoming Deadlines for June and July

June Events at the Genetic Resources Core Facility
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center